ECSP972113A - INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED BIARILOXOBUTIRIC ACIDS - Google Patents
INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED BIARILOXOBUTIRIC ACIDSInfo
- Publication number
- ECSP972113A ECSP972113A ECSP972113A ECSP972113A EC SP972113 A ECSP972113 A EC SP972113A EC SP972113 A ECSP972113 A EC SP972113A EC SP972113 A ECSP972113 A EC SP972113A
- Authority
- EC
- Ecuador
- Prior art keywords
- compounds
- disorders
- diseases
- graph
- pharmaceutical compositions
- Prior art date
Links
- 239000011159 matrix material Substances 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000035475 disorder Diseases 0.000 abstract 3
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 206010053555 Arthritis bacterial Diseases 0.000 abstract 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 abstract 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 abstract 1
- 208000016192 Demyelinating disease Diseases 0.000 abstract 1
- 206010053177 Epidermolysis Diseases 0.000 abstract 1
- 208000004575 Infectious Arthritis Diseases 0.000 abstract 1
- 206010060820 Joint injury Diseases 0.000 abstract 1
- 102000005741 Metalloproteases Human genes 0.000 abstract 1
- 108010006035 Metalloproteases Proteins 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000028911 Temporomandibular Joint disease Diseases 0.000 abstract 1
- 101000998548 Yersinia ruckeri Alkaline proteinase inhibitor Proteins 0.000 abstract 1
- 208000007474 aortic aneurysm Diseases 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 201000007717 corneal ulcer Diseases 0.000 abstract 1
- 208000002528 coronary thrombosis Diseases 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000028709 inflammatory response Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000003475 metalloproteinase inhibitor Substances 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 210000000653 nervous system Anatomy 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 208000028169 periodontal disease Diseases 0.000 abstract 1
- 201000001474 proteinuria Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 201000001223 septic arthritis Diseases 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se presentan compuestos inhibidores de la metaloproteasa de matriz, composiciones farmacéuticas de los mismos y un método de tratamiento de enfermedades mediante el uso de dichos compuestos. Los compuestos de la presente invención tiene la fórmula generalizada. (gráfico), donde r es 0-2, T es seleccionado entre (gráfico), y R40 es una estructura mono-o bi-heterocíclica. Estos compuestos son útiles para inhibir las metaloproteasas de matriz y, por lo tanto, para combatir los trastornos a los cuales contribuyen las MMP, tales como la osteoartritis, la artritis reumatoidea, la artritis séptica, las enfermedades periodontales, las úlceras de córneas, la proteinuria, la enfermedad de aneurisma aórtico, la epidermólisis vesicular distrófica, los trastornos que producen respuestas inflamatorias, la esteopenias en las que media la actividad de MMP, la enfermedad de la articulación temporomandibular, las enfermedades desmielinizantes del sistema nervioso, las metástasis de tumores o la pérdida degenerativa de cartilago posterior a la lesión articular traumática, y la trombosis coronaria por ruptura de placa ateroesclerótica. La presente invención presenta así mismo composiciones farmacéuticas y métodos para tratar dichos trastornos.Matrix metalloprotease inhibitor compounds, pharmaceutical compositions thereof and a method of treating diseases by using such compounds are presented. The compounds of the present invention have the generalized formula. (graph), where r is 0-2, T is selected from (graph), and R40 is a mono- or bi-heterocyclic structure. These compounds are useful for inhibiting matrix metalloproteases and, therefore, for combating disorders to which MMPs contribute, such as osteoarthritis, rheumatoid arthritis, septic arthritis, periodontal diseases, corneal ulcers, proteinuria, aortic aneurysm disease, dystrophic vesicular epidermolysis, disorders that produce inflammatory responses, steopenias in which MMP activity mediates, temporomandibular joint disease, demyelinating diseases of the nervous system, tumor metastasis, or degenerative loss of cartilage after traumatic joint injury, and coronary thrombosis due to ruptured atherosclerotic plaque. The present invention also presents pharmaceutical compositions and methods for treating said disorders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972113 ECSP972113A (en) | 1997-05-12 | 1997-05-12 | INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED BIARILOXOBUTIRIC ACIDS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP972113 ECSP972113A (en) | 1997-05-12 | 1997-05-12 | INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED BIARILOXOBUTIRIC ACIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP972113A true ECSP972113A (en) | 1998-04-24 |
Family
ID=42042944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP972113 ECSP972113A (en) | 1997-05-12 | 1997-05-12 | INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED BIARILOXOBUTIRIC ACIDS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP972113A (en) |
-
1997
- 1997-05-12 EC ECSP972113 patent/ECSP972113A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2056810T3 (en) | DERIVATIVES OF PHOSPHINIC ACID. | |
| AR001999A1 (en) | DERIVATIVES OF CARBOXYLIC ACID AND COMPOSITIONS CONTAINING THEM, USEFUL AS INHIBITORS OF MATRIX METALOPROTEASE, AND PROCESSES FOR THEIR PREPARATION. | |
| ES2136037B1 (en) | SULFAMIDE-METALOPROTEASE INHIBITORS | |
| AR007098A1 (en) | MATRIX METALOPROTEASE INHIBITORS, COMPOSITIONS UNDERSTANDING THEM, AND USE OF THEM TO PREPARE PHARMACEUTICAL COMPOSITIONS | |
| HN1997000067A (en) | SUBSTITUTED OXYBUTYRIC ACIDS AS MATRIX METALOPROTEASE INHIBITORS | |
| BR9713186A (en) | 1,3-diheterocyclic metalloprotease inhibitors | |
| ES2181803T3 (en) | 4-BIARILBUTIRIC OR 5-BIARILPENTANOIC SUBSTITUTED ACIDS AND THEIR DERIVATIVES AS INHIBITORS OF MATRIX METALOPROTEASES. | |
| UY24880A1 (en) | ARILSULFONIL HYDROXAMIC ACID DERIVATIVES | |
| PE30298A1 (en) | MATRIX METALLOPROTEASE INHIBITORS | |
| AR002718A1 (en) | HYDROXAMIC ACIDS THAT CONTAIN LACTAMS AND PHARMACEUTICAL COMPOSITION WITH THE SAME. | |
| BR0010555A (en) | Neuraminidase Inhibitors | |
| UY24881A1 (en) | 2-AMINO-6- (4-PHENOXI-2-SUBSTITUTED) -PIRIDINES SUBSTITUTED | |
| AR007100A1 (en) | INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED PHENYLALKYL COMPOUNDS AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT. | |
| YU18397A (en) | MATRIX METALLOPROTEASES INHIBITING COMPOUND, 2(ω-ARYOYL-ALKYL)-4-BIARYL-4-OXOBUTYRIC ACID | |
| AR007097A1 (en) | BIARYLACETHYLENE MATRIX METALOPROTEASE INHIBITORS, A COMPOSITION THAT HAS MATRIX METALOPROTEASE INHIBITING AND THE USE OF SUCH BIARYLACETILENE IN THE MANUFACTURE OF A MEDICINAL PRODUCT. | |
| ECSP972113A (en) | INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED BIARILOXOBUTIRIC ACIDS | |
| AR007096A1 (en) | MATRIX METALOPROTEASE INHIBITOR COMPOUND METHOD FOR INHIBITING ITS ACTIVITY, A CONTAINING COMPOSITION AND USE OF SUCH COMPOUNDS TO PREPARE PHARMACEUTICAL COMPOSITIONS | |
| ECSP972112A (en) | INHIBITION OF MATRIX METALOPROTEASES BY SUBSTITUTED FENETILE COMPOUNDS | |
| ECSP972111A (en) | MATRIX METALOPROTEINASES INHIBITORS BY ACIDS 2- (AROILALQUIL) -4 BIARIL-4- OXOBUTIRICOS | |
| ECSP972114A (en) | BIARYLACETYLENE AS INHIBITORS OF MATRIX METALOPROTEASE | |
| UY26079A1 (en) | NEW DERIVATIVES OF MORPHOLINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| ECSP972115A (en) | SUBSTITUTED OXYBUTYRIC ACIDS AS MATRIX METALOPROTEASE INHIBITORS | |
| MX9307048A (en) | DERIVATIVES OF PIRIDAZINOQUINAZOLONA, AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM. | |
| PT1077694E (en) | ARILNITRONE THERAPEUTIC PRODUCTS FOR THE TREATMENT OF DOINESTINE INFLAMMATORY DISEASE | |
| ES2123796T3 (en) | DERIVATIVES OF PHOSPHONE-SUCCINIC ACIDS AND THEIR USE AS MEDICINES. |